Abingworth is a venture capital firm founded in 1973. The firm's headquarters is located in London, United Kingdom, with additional offices in the United States at San Francisco and Boston. As of October 2019, Abingworth has sold off its ownership in 134 companies and is currently managing a portfolio of 25 companies.
Abingworth focuses on funding companies based in Europe and the United States. Sector-wise, Abingworth provides funding for companies in the life sciences industry, with a specific interest in fields such as biotherapeutics, small molecules, nucleic acid therapeutics, and vaccines. For each company, the firm allocates an investment total at a range of $15-$30 million.
Labcyte is a global biotechnology tools company headquartered in San Jose, California, that develops tools for liquid handling.
A company focused on development of products to treat central nervous system disorders, pain and rare diseases
A company developing therapies for psychological and neurological illnesses
A company focused on the discovery and development of treatments for rare inherited diseases.
A molecular diagnostics for oncology company
A company developing RNA-based therapeutics for genetic disorders, infections and cancer
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
VirionHealth is a biotechnology company
VenatoRx Pharmaceuticals is a Malvern, Pennsylvania-based company.
Gynesonics is a Redwood City, California-based healthcare company.
Chiasma Pharma is a Waltham, Massachusetts-based company.
SutroVax is a Foster City, California-based biopharmaceutical company.
Partner, Portfolio Manager
Partner and CFO
Partner and General Counsel
Kurt von Emster
Partner, Marketing and Talent
Chairman & Managing Partner
Documentaries, videos and podcasts